These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3811635

  • 1. [Synovial tissue levels in comparison with synovial fluid and serum concentrations following a single daily administration of 20 mg piroxicam (Felden)].
    Thabe H, Fassbender HG, Laufen H, Gierend M.
    Z Rheumatol; 1986; 45(5):271-6. PubMed ID: 3811635
    [Abstract] [Full Text] [Related]

  • 2. Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester.
    Chérié Lignière G, Montagnani G, Alberici M, Acerbi D.
    Arzneimittelforschung; 1987 May; 37(5):560-3. PubMed ID: 3619977
    [Abstract] [Full Text] [Related]

  • 3. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J, Luckow V, Guserle R, Pässler HH.
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [Abstract] [Full Text] [Related]

  • 4. Anti-prostaglandin and anti-inflammatory short-term efficacy of piroxicam in rheumatoid arthritis.
    Strusberg A, Montrull H, Meirovich CI.
    Eur J Rheumatol Inflamm; 1983 Aug; 6(1):41-5. PubMed ID: 6574910
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Trans-synovial kinetics of tiaprofenic acid].
    Kurowski M.
    Z Rheumatol; 1988 Aug; 47(3):173-6. PubMed ID: 3213265
    [Abstract] [Full Text] [Related]

  • 8. [Plasma- and tissue concentrations following intramuscular administration of etofenamat. Pharmacokinetics of etofenamat and flufenamic acid in plasma, synovium, and tissues of patients with chronic polyarthritis after administration of an oily solution of etofenamat].
    Köhler G, Tressel W, Dell HD, Doersing M, Fischer W, Kamp R, Langer M, Richter B, Wirzbach E.
    Arzneimittelforschung; 1992 Dec; 42(12):1487-91. PubMed ID: 1288513
    [Abstract] [Full Text] [Related]

  • 9. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis.
    Foell D, Kane D, Bresnihan B, Vogl T, Nacken W, Sorg C, Fitzgerald O, Roth J.
    Rheumatology (Oxford); 2003 Nov; 42(11):1383-9. PubMed ID: 12832707
    [Abstract] [Full Text] [Related]

  • 10. Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis.
    Haq A, El-Ramahi K, Al-Dalaan A, Al-Sedairy ST.
    J Med; 1999 Nov; 30(1-2):51-60. PubMed ID: 10515240
    [Abstract] [Full Text] [Related]

  • 11. [Indomethacin kinetics in synovia and plasma following administration of indomethacin Gits 7/85 in patients with chronic polyarthritis].
    Zöller B, Zimmer M, Dittrich P, Lehmann K, Engel HJ, Faust-Tinnefeldt G, Kukovetz WR.
    Z Rheumatol; 1983 Nov; 42(2):78-81. PubMed ID: 6880406
    [Abstract] [Full Text] [Related]

  • 12. Piroxicam therapy: a double blind, randomized, multicenter study comparing 2 versus 4 week treatment in patients with painful knee osteoarthritis with effusion.
    Ravaud P, Auleley GR, Ayral X, Marre JP, Amor B.
    J Rheumatol; 1998 Dec; 25(12):2425-31. PubMed ID: 9858440
    [Abstract] [Full Text] [Related]

  • 13. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis.
    Menkes CJ, Renoux M, Laoussadi S, Mauborgne A, Bruxelle J, Cesselin F.
    J Rheumatol; 1993 Apr; 20(4):714-7. PubMed ID: 7684449
    [Abstract] [Full Text] [Related]

  • 14. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA, Allen JG, Dixon JS, Wright V.
    Eur J Rheumatol Inflamm; 1985 Apr; 8(1):47-52. PubMed ID: 3879830
    [Abstract] [Full Text] [Related]

  • 15. Clinical and laboratory changes produced by piroxicam in rheumatoid arthritis.
    De Zubiria RC, Charria A, Lobo Guerrero D.
    Eur J Rheumatol Inflamm; 1983 Apr; 6(1):56-62. PubMed ID: 6861814
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Relation between clinical response and plasma and synovial fluid levels of piroxicam].
    Chérié Lignière G.
    Clin Ter; 1984 Feb 29; 108(4):297-304. PubMed ID: 6232066
    [No Abstract] [Full Text] [Related]

  • 18. [Dynamics of interleukin (IL)-18 in serum, synovial fluid and synovial membrane in the patients with rheumatoid arthritis].
    Munakata T, Uzuki M, Shimamura T, Sawai T.
    Ryumachi; 2001 Jun 29; 41(3):625-34. PubMed ID: 11505512
    [Abstract] [Full Text] [Related]

  • 19. [The production of superoxide anion (O2-) by polymorphonuclear cells in patients with rheumatoid arthritis].
    Lalumera M, Berti C, Pellegrini R, Morozzi G, Marcolongo R.
    Boll Soc Ital Biol Sper; 1982 Apr 15; 58(7):385-91. PubMed ID: 6282291
    [Abstract] [Full Text] [Related]

  • 20. Diminished superoxide production of synovial fluid neutrophils in patients with rheumatoid arthritis following piroxicam treatment.
    Biemond P, Han H, Swaak AJ, Koster JF.
    Scand J Rheumatol; 1990 Apr 15; 19(2):151-6. PubMed ID: 2159656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.